IDF 2021 Programme Committee and Streams

Last update: 29/01/2021
IDF21 committee 1400px


Learning Objectives

View the learning objectives of each stream (pdf).

Meet the stream leads

  • Programme Chair: Jonathan Shaw, Australia

    Jonathan Shaw MD, FRCP (UK), FRACP, FAAHMS is Deputy Director at Melbourne’s Baker Heart and Diabetes Institute. He is also an endocrinologist, Chair of the Diabetes Advisory Group to the Australian Institute of Health and Welfare (AIHW), Council Member of the Australian Diabetes Society, and Past-President of the International Diabetes Epidemiology Group. His awards include the International Diabetes Epidemiology Group (IDEG) Peter Bennett award (2011), the Australian Diabetes Society (ADS) Jeff Flack Diabetes Data award (2015), and the ADS Kellion Diabetes award (2018). He has authored more than 400 peer-reviewed scientific papers and 35 book chapters, and was included in the Thomson Reuters The World’s Most Influential Scientific Minds (2014), and the Clarivate Analytics list of the world’s most Highly Cited Researchers (2017 and 2018). His areas of interest include epidemiology and clinical trials in diabetes.

  • Vice Chair: João Valente Nabais, Portugal

    João Valente Nabais PhD is Assistant Profesor with Habilitation at University of Evora (Portugal). Diagnosed with type 1 diabetes in 1981, João has been actively involved in the field of diabetes through his work at national and international level. He has been involved in diabetes camps and the development of education courses for people with diabetes and parents of children with diabetes, and oversaw the launch of the IDF Europe Youth Leadership Camp. João is a member of the Comprehensive Health Research Center and a consultant to the Portuguese Diabetes Association (APDP). He is a Past President of the IDF European Region (2012-15) and currently a Vice-President of IDF. He has published 60 papers in international journals, participated in 15 R&D projects as Researcher and is the co-author of 3 patents.

  • Basic and Translational Science: Paula Macedo, Portugal

    Paula Macedo is currently Professor at the NOVA Medical School, NOVA University in Lisbon, and at the Department of Medical Sciences Universidade Aveiro, Portugal. Professor Macedo graduated in Pharmacy from the Faculty of Pharmacy at the University of Lisbon and obtained her PhD from the Department of Pharmacology and Therapeutics at the University of Manitoba, Canada. She is the principal investigator of the MEDIR group based at CEDOC NOVA Medical School. Professor Macedo has been awarded several grants as a principal investigator on her preferred research subjects in both basic and clinical research. She has been working in research areas related to hepatic vasculature and hepatic control of insulin sensitivity. Significant contributions include the description and explanation of meal-induced insulin action sensitization in prediabetes and in diabetes-related pathologies. Lately, her interests are focused on the impact of the subclinical impairments of the autonomic nervous system on glucose and lipid metabolism and in the genetics and environmental factors controlling insulin clearance and insulin resistance at the prediabetes stage, focusing on the gut-liver axis.

  • Diabetes Complications and Comorbidities: Andrea Luk

    Andrea Luk is currently the Associate Professor of the Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR. She is also the Medical Director (Non-Oncology) of the Phase 1 Clinical Trial Centre and serves as an honorary associate consultant at the Prince of Wales Hospital. Dr Luk completed her specialist training in endocrinology, reproduction and metabolism in 2007. Her research interests include epidemiology of diabetes and diabetes-related complications, study of the aetiology and mechanisms of young-onset diabetes, as well as translational studies of care models in people with diabetes.

  • Diabetes in Women: Maria Inês Schmidt

    Maria Inês Schmidt MD, PhD is an endocrinologist and epidemiologist trained at the John Hopkins Hospital and at the University of North Carolina. Professor at the School of Medicine of the Federal University of Rio Grande do Sul, Brazil where she teaches medical students and graduate students in epidemiology. Her main research focus on the epidemiology of type 2 diabetes, obesity, gestational diabetes, and diabetes prevention in women. Current main projects include: LINDA Brasil, a randomized controlled trial for the prevention of diabetes in women with recent gestational diabetes; ELSA-Brasil, a cohort study of 15105 Brazilian adults now followed-up for 10 years; Surveillance of diabetes and its complications in Brazil; and the Global Burden of Disease (GBD) project. Over the years, she has contributed to the development of IDF guidelines and acted as a panel member of various WHO consultations related to diabetes. She is a member of the Lancet Commission on Diabetes.

  • Education and Integrated Care: Zilin Sun

    Zilin Sun M.D., Ph.D., is Professor of Medicine and the Director of the Institute of Diabetes in Southeast University in Nanjing, China. Dr. Sun received his doctoral trainings in Clinical Pharmacology and Clinical Medicine from China Pharmaceutical University and Ulm University in Germany. He is now Chairman of the Chinese Association of Diabetes and Microcirculation and a Committee Member of the Chinese Society of Endocrinology. He was also the former Vice Director of the Diabetes Education and Management Group of the Chinese Diabetes Society, the former Committee member of Chinese Diabetes Society, and the former Chairman of the Jiangsu Diabetes Society. Dr. Sun is also on the editorial board of “BMC Med” and “Diabetes Metab J” and has published more than 200 scientific papers, including more than 100 SCI-indexed publications.

  • Living with Diabetes: Sana Ajmal

    Sana Ajmal is a seasoned diabetes advocate, with years of experience with various IDF programmes and activities, including Young Leaders in Diabetes, Diabetes Education Consultative Section, the World Diabetes Congress Program Committee and other international bodies. She is the Founder and Executive Director of Meethi Zindagi, which is the only national, people-centric, non-profit organization in Pakistan, providing psycho-social support, peer education and medicines to the diabetes community and empowering them to lead thriving lives. Her distinction lies in tailoring international best practices to a local perspective and simplifying complex solutions with an engineered approach and technology to create robust systems and services in resource limited settings.

  • Epidemiology and Public Health: Ayesha Motala

    Ayesha Motala is a specialist physician and currently Professor and Clinical Head in the Department of Diabetes and Endocrinology at Inkosi Albert Luthuli Central Hospital affiliated to the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

    Ayesha is a clinician and her research has focussed on the epidemiology, genetic and clinical aspects of diabetes and other non-communicable diseases (NCDs). She has been involved in several large-scale population studies, both cross-sectional and longitudinal, on the epidemiology of diabetes in African (black) and Asian Indian communities in KwaZulu Natal, both urban and rural, She is the lead principal investigator of a large consortium-wide study at 10 sites across 7 countries in sub-Saharan Africa - the Human Hereditary and Health in Africa (H3Africa) study on diabetes, funded through the Wellcome Trust.

  • Clinical, Therapeutic and Technology Research: Shashank Joshi

    Shashank R. Joshi is the Chair of the Southeast Asian Region of IDF and Dean of the Indian College of Physicians from Mumbai, India. He is Past President of the Endocrine Society of India, RSSDI and many other societies in India and Asia. He is a well-known Endocrinologist attached to Joshi Clinic and Lilavati Hospital and has published more than 800 publications and written 100 books. His areas of interest includes diabetes, diabetes therapy and obesity apart from developing low cost interventions for the developing world.

  • Health Services and Policy: Niti Pall

    Niti Pall is President of IDF Europe. She is Global Medical Director for KPMG and Senior Mobile Health Advisor for AXA. She also sits on the board of the Birmingham Women’s and Children’s Hospital. Niti is a senior Doctor who has deep expertise in primary care models and health benefit management across the world. Niti helped to build up the largest chain of primary care clinics in the UK – the Modality Partnership – and held several senior commissioning roles in the English NHS. She has innovated with new extended primary care and enhanced primary care including diabetes care across the world.

    Her interest in diabetes spans three decades as her son has had Type 1 diabetes for 27 years. She has worked in diabetes advocacy since his first diagnosis and is passionate about involving patients in driving good quality services. She established a chain of primary care clinics in India. She was Medical and Innovation Director of Emerging Markets for BUPA, where she helped to create an innovative model of micro-insurance in Bangladesh, in partnership with Telenor.

    She established and supervised clinics in China, Saudi Arabia, Poland and Hong Kong and helped create health benefit management systems in Saudi Arabia, UK, India, Hong Kong, and Thailand. She has delivered universal healthcare work in India, Middle east Kazakhstan , Philippines , Sri Lanka and Indonesia. She is currently working with 8 AXA countries developing mobile health propositions that include new funding products for emerging customers. This has included digital new technologies for diabetes care at an affordable cost. Affordable healthcare remains a passion and an interest.

© 2021 International Diabetes Federation Disclaimer Privacy policy